Brivaracetam Sustained-Release Tablets(Shanghai Aucta Pharma)
布立西坦缓释片（上海奥科达医药）
Report date: 2025/11/13 16:57:34
Base Information
Drug NameBrivaracetam Sustained-Release Tablets(Shanghai Aucta Pharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Aucta Pharmaceuticals Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesShanghai Aucta Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A